WST
West Pharmaceutical ServicesDNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
Current thesis
Bull: successful execution on capacity expansion, steady margin improvement, and one or more favorable analyst upgrades that re-rate multiples; supports material upside versus the anchor within 12 months.
Posture
Defensive
Lead driver
Momentum
What changed
9 setup hits (3d) with net bullish as of 2026-06-03.
What can break
Analyst downgrades / multiple compression
Momentum
80
Value
60
Sentiment
0
Setup hits (3d)
9 · Net Bullish
AI TargetsBase $15.19 · Bull $22.10 · Bear $8.29
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-15 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Bullish
Target $322.43
Why
Momentum80 · Δ7d -6.2
Value60 · Δ7d +0.1
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Bullish). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
80
34% active weight
Current posture
7d trendSoftening
Δ7d
-6.2
Δ21d
-7.5
Value
60
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
0
33% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade D. Momentum 79.8 / Value 60.1 / Sentiment 0.0
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$22.05B
Beta
1.18
Shares Out
71.94M
P/E (TTM)
41.3
P/S (TTM)
6.65
P/FCF (TTM)
63.05
Rev YoY
+7.7%
EPS YoY
+4.1%
Gross Margin
+35.6%
Op Margin
+19.5%
Net Debt
-$279M
Current Ratio
2.87
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology